|
US2009216029A1
|
|
Process for the production of atorvastatin calcium in amorphous form
|
|
WO2006035300A2
|
|
A process for the preparation of meropenem
|
|
WO2006046096A2
|
|
A polymorphic form of narwedine and its use in the synthesis of galantamine
|
|
WO2006013546A2
|
|
Process for the preparation of pure galantamine
|
|
US2008262025A1
|
|
Processes for the Preparation of Zolpidem and its Hemitartrate
|
|
WO2005123033A2
|
|
Fine particles of cilostazol and processes for production thereof
|
|
WO2005044824A2
|
|
Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin
|
|
WO2005016936A2
|
|
Process for selective preparation of z-isomer of cefditoren and pharmaceutically acceptable salts and esters thereof
|
|
WO2005012227A2
|
|
Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
|
|
US2007129549A1
|
|
Stable lamotrigine pharmaceutical compositions and processes for their preparation
|
|
US2006211761A1
|
|
Hmg-coa-reductase inhibitors
|
|
US6822119B1
|
|
Process for the preparation of tolterodine
|
